BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22392635)

  • 1. Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase.
    Gomez-Santos L; Luka Z; Wagner C; Fernandez-Alvarez S; Lu SC; Mato JM; Martinez-Chantar ML; Beraza N
    Hepatology; 2012 Aug; 56(2):747-59. PubMed ID: 22392635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency.
    Fernández-Álvarez S; Gutiérrez-de Juan V; Zubiete-Franco I; Barbier-Torres L; Lahoz A; Parés A; Luka Z; Wagner C; Lu SC; Mato JM; Martínez-Chantar ML; Beraza N
    Lab Invest; 2015 Feb; 95(2):223-36. PubMed ID: 25531568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
    Beraza N; Malato Y; Sander LE; Al-Masaoudi M; Freimuth J; Riethmacher D; Gores GJ; Roskams T; Liedtke C; Trautwein C
    J Exp Med; 2009 Aug; 206(8):1727-37. PubMed ID: 19635861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
    Martínez-Chantar ML; Vázquez-Chantada M; Ariz U; Martínez N; Varela M; Luka Z; Capdevila A; Rodríguez J; Aransay AM; Matthiesen R; Yang H; Calvisi DF; Esteller M; Fraga M; Lu SC; Wagner C; Mato JM
    Hepatology; 2008 Apr; 47(4):1191-9. PubMed ID: 18318442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated transmethylation leading to hepatocellular carcinoma compromises redox homeostasis and glucose formation.
    Hughey CC; James FD; Wang Z; Goelzer M; Wasserman DH
    Mol Metab; 2019 May; 23():1-13. PubMed ID: 30850319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.
    Fang CC; Wu CF; Liao YJ; Huang SF; Chen M; Chen YA
    Sci Rep; 2018 Sep; 8(1):13802. PubMed ID: 30217986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis.
    Liao YJ; Chen TL; Lee TS; Wang HA; Wang CK; Liao LY; Liu RS; Huang SF; Chen YM
    Mol Med; 2012 May; 18(1):412-22. PubMed ID: 22183894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine
    Hughey CC; Trefts E; Bracy DP; James FD; Donahue EP; Wasserman DH
    J Biol Chem; 2018 Jul; 293(30):11944-11954. PubMed ID: 29891549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress.
    Quinn C; Rico MC; Merali C; Merali S
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis.
    Borowa-Mazgaj B; de Conti A; Tryndyak V; Steward CR; Jimenez L; Melnyk S; Seneshaw M; Mirshahi F; Rusyn I; Beland FA; Sanyal AJ; Pogribny IP
    Toxicol Sci; 2019 Aug; 170(2):273-282. PubMed ID: 31086990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.
    Varela-Rey M; Martínez-López N; Fernández-Ramos D; Embade N; Calvisi DF; Woodhoo A; Rodríguez J; Fraga MF; Julve J; Rodríguez-Millán E; Frades I; Torres L; Luka Z; Wagner C; Esteller M; Lu SC; Martínez-Chantar ML; Mato JM
    Hepatology; 2010 Jul; 52(1):105-14. PubMed ID: 20578266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
    Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
    Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.
    Fernández-Tussy P; Fernández-Ramos D; Lopitz-Otsoa F; Simón J; Barbier-Torres L; Gomez-Santos B; Nuñez-Garcia M; Azkargorta M; Gutiérrez-de Juan V; Serrano-Macia M; Rodríguez-Agudo R; Iruzubieta P; Anguita J; Castro RE; Champagne D; Rincón M; Elortza F; Arslanow A; Krawczyk M; Lammert F; Kirchmeyer M; Behrmann I; Crespo J; Lu SC; Mato JM; Varela-Rey M; Aspichueta P; Delgado TC; Martínez-Chantar ML
    Mol Metab; 2019 Nov; 29():40-54. PubMed ID: 31668391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.
    Li Z; Oben JA; Yang S; Lin H; Stafford EA; Soloski MJ; Thomas SA; Diehl AM
    Hepatology; 2004 Aug; 40(2):434-41. PubMed ID: 15368448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.
    Kahraman A; Barreyro FJ; Bronk SF; Werneburg NW; Mott JL; Akazawa Y; Masuoka HC; Howe CL; Gores GJ
    Hepatology; 2008 Apr; 47(4):1317-30. PubMed ID: 18220275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells.
    Chen Y; Wei H; Sun R; Dong Z; Zhang J; Tian Z
    Hepatology; 2007 Sep; 46(3):706-15. PubMed ID: 17626270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma.
    Kant R; Yen CH; Lu CK; Lin YC; Li JH; Chen YM
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses.
    Vinay DS; Choi BK; Bae JS; Kim WY; Gebhardt BM; Kwon BS
    J Immunol; 2004 Sep; 173(6):4218-29. PubMed ID: 15356173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.
    Kremer M; Hines IN; Milton RJ; Wheeler MD
    Hepatology; 2006 Jul; 44(1):216-27. PubMed ID: 16799967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
    Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
    Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.